WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?

In this article describing the rollout of the malaria vaccine in Africa, authors recommend that the pilot studies use “overall mortality” to assess vaccine performance and that study populations are followed for 4-5 years before a final decision on rollout is made.


British Medical Journal